How HIV Takes Advantage of the Cytoskeleton in Entry and Replication by Stolp, Bettina & Fackler, Oliver T.






How HIV Takes Advantage of the Cytoskeleton in Entry and 
Replication 
Bettina Stolp and Oliver T. Fackler * 
Department of Infectious Diseases, Virology, University Hospital Heidelberg, Im Neuenheimer Feld 
324, D-69120 Heidelberg, Germany; E-Mail: bettina.stolp@med.uni-heidelberg.de 
*  Author to whom correspondence should be addressed;  
E-Mail: oliver.fackler@med.uni-heidelberg.de; Tel.: +49-6221-56-1322; Fax: +49-6221-56-5003. 
Received: 2 February 2011; in revised form: 11 March 2011 / Accepted: 19 March 2011 /  
Published: 28 March 2011 
 
Abstract: The host cell cytoskeleton plays a key role in the life cycle of viral pathogens 
whose propagation depends on mandatory intracellular steps. Accordingly, also the human 
immunodeficiency virus type 1 (HIV-1) has evolved strategies to exploit and modulate in 
particular  the  actin  cytoskeleton  for  its  purposes.  This  review  will  recapitulate  recent 
findings on how HIV-1 hijacks the cytoskeleton to facilitate entry into, transport within 
and  egress  from  host  cells  as  well  as  to  commandeer  communication  of  infected  with 
uninfected bystander cells. 
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1. Introduction  
Dynamic  cellular  processes  such  as  cell  motility,  cell  division,  intracellular  transport  and 
endocytosis depend on the cytoskeleton comprised of actin, microtubule and intermediate filament 
systems [1–3]. As obligate intracellular pathogens, viruses rely on host cell machinery for most steps 
in  their  replication  cycle  and  thus  depend  on  functional  interactions  with  cytoskeletal  elements. 
Consequently, viruses have evolved optimized replication strategies that include manipulations of the 
cellular  actin  and  microtubule  cytoskeleton  in  their  host  cells.  In  the  case  of  the  human 
immunodeficiency virus type 1 (HIV-1) the actin cytoskeleton represents a significant physical barrier 
during virus entry. Furthermore, intracellular transport of incoming genomes towards the nucleus and 
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of virion components to budding sites appears to require functional interactions with the host cell 
cytoskeleton.  Finally,  cytoskeletal  manipulations  are  employed  as  a  convenient  tool  to  tailor 
communication of  infected cells  with the  environment. To this  end, the HIV-1 encoded structural 
proteins Gag and Env but also the accessory proteins Nef, Rev, Tat and Vif have been reported to 
interact with  and/or affect  host cell cytoskeletal structures. In this review we will  summarize our 
current understanding of HIV-1’s interaction with the host cell cytoskeleton with a particular emphasis 
on  events  during  virus  entry  as  well  as  on  the  role  of  the  Nef  protein  as  an  inhibitor  of  
F-actin remodeling. 
2. The Role of the Cytoskeleton in the HIV Life Cycle 
2.1. Entry 
Entry of HIV-1 into target cells is a highly coordinated multi-step process that is understood in 
great molecular detail [4,5]. Initial cell attachment of HIV-1 mainly occurs via unspecific binding to 
lectins,  glycosaminoglycans  or  via  receptor-ligand  interactions  of  virion  incorporated  cell  surface 
proteins [6–8] (Figure 1A, steps 2 and 3). Subsequent entry requires binding of the viral envelope 
glycoprotein gp120 to its primary entry receptor CD4, resulting in a conformational change in gp120 
that exposes the binding site for one of the HIV-1 entry co-receptors CCR5 or CXCR4. Co-receptor 
binding induces gp41 fusion peptide insertion into the host cell membrane and subsequent six-helix 
bundle  formation  approaches  viral  and  cellular  membranes,  resulting  in  membrane  fusion  and 
subsequent release of the viral core into the cytosol (reviewed in [9]). The cortical actin cytoskeleton is 
involved in this process at least in two steps: First, during the initial phase in which entry receptors 
need to be clustered for efficient entry (Figure 1A, step 5). Second, following the fusion reaction, 
cytoskeletal rearrangements facilitate release of the viral core into the cytoplasm (Figure 1A, steps 9 
and  10).  In  both  cases,  HIV-1  modulates  these  events  by  binding  of  gp120  to  its  receptor  and 
coreceptor, which elicits signaling pathways that alter dynamic cytoskeleton remodeling (Figure 1). 
The  exact  spatiotemporal  sequence  of  these  signaling  events  is  poorly  understood,  but  it  is  well 
accepted that HIV binding induces signaling cascades similar to the natural receptor ligands. We will 
summarize below our current understanding of these cytoskeletal-dependent steps in HIV-1 entry. 
2.1.1. Entry Receptor Clustering and Cytoplasmic Delivery of Virion Cores 
One of the first challenges incoming HIV-1 virions meet on their way to productive infection is to 
locally enrich CD4 and co-receptor for coordinated membrane fusion (Figure 1A, step 5). Several 
studies  indicate  that  HIV-1  solves  this  problem  by  inducing  a  signaling  cascade  that  triggers  
actin-dependent  clustering  of  HIV-1  entry  receptors  to  reduce  their  lateral  mobility  and  thus  to 
establish signaling platforms that stabilize fusion pore formation [10–13]. This is achieved by binding 
of  gp120  to  CD4  and  the  chemokine  entry  co-receptors  which  induces  recruitment  of  the 
membrane-actin crosslinker  filaminA to physically  link the cytoplasmic tails of these receptors to  
F-actin [10,13]. This stabilization facilitates subsequent conformational changes of gp120 required for 
membrane  fusion.  Importantly,  gp120-receptor  interactions  per  se  do  not  automatically  result  in 
reduced receptor mobility. This fact is exploited by retroviruses including HIV-1, which, while bound Viruses 2011, 3                                       
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to their entry receptors at the target cell surface, benefit from actin-driven mobility of these receptors 
to reach subcellular sites with optimized conditions  for virus  entry [14]. How this process that is 
referred to as “virus surfing” is coordinated with arrest of receptor movement and triggering of fusion 
will be an interesting area of research in coming years.  
Figure 1. Proposed signaling pathway to the actin cytoskeleton during HIV-1 entry in T 
lymphocytes. (a) Mature free virions (step 1) are initially captured by unspecific binding to 
glycoproteins covering the target cell such as glycosaminoglycans (GAG, step 2) or cell 
surface molecules such as LFA-1 or DC-SIGN (step 3). Subsequent specific binding of 
gp120 to CD4 initiates signaling to moesin, Arp2/3 and filaminA (step 4), resulting in 
entry  receptor  clustering  (step  5).  This  allows  gp120  to  engage  chemokine  entry 
coreceptors to initiate receptor signaling, whose downstream effects include activation of 
cofilin (step 6). Active cofilin and Arp2/3 locally loosen the cortical actin cytoskeleton and 
provide motility (steps 7 and 8), to facilitate release of the viral core into the cytoplasm and 
transport  through  the  cortical  actin,  respectively  (steps  9  and  10).  (b)  Schematic 
representation  of  the  current  understanding  of  signaling  cascades  induced  by  gp120 
through binding to CD4 (left panel) and CXCR4/CCR5 (right panel) during HIV-1 entry. 
Note that these pathways may be distinct in HIV-1 target cells such as macrophages that 
lack expression of T cell specific factors such as Lck. 
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Subsequent  to  successful  clustering  of  entry  receptors  and  initiation  of  membrane  fusion,  the 
cortical actin cytoskeleton represents a barrier to the delivery of viral cores into the cytoplasm. This 
hurdle is again overcome by signals derived from gp120-receptor interactions, in particular with the 
chemokine co-receptors. Chemokine receptors are a large family of seven transmembrane serpentine 
receptors that are coupled to heterotrimeric G proteins on the inner leaflet of the plasma membrane to 
trigger signaling upon engagement. Downstream effector cascades are predominantly determined by 
the nature of the coupled heterotrimeric G proteins. In the case of HIV-1 gp120 and CXCR4/CCR5, 
signaling  seems  to  occur  mainly  via  Gq  or  GI  [15,16].  Physiological  chemokine  receptor-G 
signaling typically results  in the activation of Rho-GTPases  via  induction of a  complex signaling 
pathway (Figure 1B, right panel). HIV-1 mimics this cascade and triggers Rho GTPase activation, 
however which specific GTPases are targeted is still a matter of debate. Roles for activation of RhoA 
as well as Rac1 have been reported [13,15,17–20]. These findings are not mutually exclusive and may 
reflect that RhoA activation occurs via CD4 engagement, whereas Rac1 is activated downstream of 
chemokine  co-receptors.  Irrespective  of  the  specific  GTPase  involved,  many  components  of  the 
signaling pathway have been identified (Figure 1B) that directly target the actin remodeling machinery 
of the host cell. One important target appears to be the Arp2/3 complex, a large protein assembly 
regulated by Rac1 that exerts nucleation activity for the de novo formation of F-actin filaments. Arp2/3 
activity is induced by HIV-1 Env-chemokine receptor interactions, an activity essential for efficient 
HIV entry [18,21]. More recently, the actin severing factor cofilin has been identified as an additional 
target of Env-mediated signaling during HIV entry and its activity is regulated in a biphasic manner. 
Cofilin is phosphorylated and thereby inactivated via a RhoA and Rac-dependent pathway downstream 
of CD4 and CXCR4, respectively, within seconds of HIV binding to a target cell [13,22]. Since cofilin 
inactivation reduces actin remodeling, this effect may contribute to efficient receptor clustering. In 
subsequent  steps  of  HIV-1  entry,  cofilin  is  dephosphorylated  and  thus  activated,  leading  to  the 
fragmentation of existing actin filaments and thus presumably loosening of the actin cortex [16,23]. 
This rapid switch of cofilin activation states during HIV-1 entry resembles those observed following 
physiological  chemokine  receptor  engagement  where  a  rapid  (within  seconds)  and  transient 
phosphorylation is followed by a prolonged (20–30 minutes) phase of cofilin activation [22,24–26]. 
This elegant combination of activation of Arp2/3 and cofilin conceivably results in enhanced actin 
remodeling in the cell periphery, which is thought to facilitate delivery of the viral core through the 
otherwise rigid cell periphery. Movement of viral cores near the plasma membrane has been shown to 
be actin and microtubule dependent [27,28] and may be initiated by cofilin-dependent free barbed end 
production and Arp2/3 facilitated F-actin polymerization. 
Even though signaling pathways elicited by CD4 and the co-receptors are not easy to distinguish 
due to overlapping downstream signaling pathways, evidence based on the use of receptor specific 
blocking antibodies is emerging that CD4 binding also triggers selective signaling that contributes to 
efficient  HIV-1  entry.  At  early  entry  steps,  CD4  engagement  has  been  shown  to  activate  the 
membrane-actin crosslinking protein moesin to facilitate entry receptor clustering and thus efficient 
entry [12] (Figure 1A, steps 4–6). Similarly at later steps, CD4 specific signals trigger, via a yet to be 
resolved  mechanism,  the  inactivation  of  the  histone  deacetylase  6  (HDAC6),  which  results  in  an 
increased  level of acetylated and thus stabilized  microtubules (Figure 1B,  left panel). Possibly  by Viruses 2011, 3                                       
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stabilizing fusion pores for delivery of viral cores to the cytoplasm, formation of these rigid structures 
potently facilitates productive HIV-1 entry [29].  
2.1.2. Sensitization of Uninfected Bystander Cells for Entry 
Consistent with the analogy between signaling triggered by HIV-1 co-receptor chemokine ligands 
and gp120, pretreatment of HIV permissive cells with chemokines binding to the HIV co-receptors 
facilitates replication by priming the cell for subsequent infection [23]. Recent results indicate that 
HIV-1 exploits this phenomenon to prime uninfected non-activated CD4
+ T lymphocytes in infected 
patients, a cell population that is typically rather refractory to viral  infection. This  is achieved  by 
shedding  of  gp120  molecules  from  productively  infected  cells,  resulting  in  elevated  serum 
concentrations of gp120 sufficient for triggering of baseline chemokine receptor signaling. Similar to 
events during the actual infection process, this may enhance cofilin activity to increase the turnover of 
cortical actin and thus to facilitate passage of incoming virions through the otherwise rigid actin cortex 
[23,30].  It thus  emerges  that  HIV-1  may  have  specifically  evolved  loose  interactions  between  its 
glycoprotein subunits that lead to shedding of gp120, thereby recycling the mechanism involved in 
productive entry of immediate target cells for priming of future targets. 
2.1.3. Requirement for Cytoskeletal Interactions during Endocytic Entry? 
Historically, HIV-1 entry was believed to occur predominantly or even exclusively at the plasma 
membrane [5]. More recently, however, evidence accumulates for a prominent role of fusion with 
endosomal  membranes  following  endocytosis  in  productive  HIV-1  infection  [4,20,31–36].  Most 
studies on the role of the host cell cytoskeleton in HIV-1 entry did not distinguish between productive 
entry events occurring at the plasma membrane or following endocytic uptake. It remains thus unclear 
whether endocytic and plasma membrane entry routes of HIV-1 differ in their requirements for actin 
remodeling. The endocytic route arguably provides incoming virions with the advantage that, as cargo 
of an endocytic vesicle, the cortical actin barrier can be overcome without a need for virus-induced 
cytoskeletal rearrangements. While the actin cytoskeleton does not seem to play an essential role for 
the  budding  of  such  endocytic  vesicles,  evidence  is  accumulating  that  specific  actin  nucleation 
machineries are recruited to individual types of endosomal vesicles to drive their motility and thus 
possibly productive HIV-1 infection [37,38]. However, the precise endocytic route via which HIV 
enters target cells is only poorly defined and endocytic pathways rely to different extents on dynamic 
actin remodeling for uptake and intracellular trafficking  [39]. Moreover, endocytic entry of HIV-1 
likely  occurs  via  very  distinct  uptake  routes  in  diverse  target  cells  such  as  T  lymphocytes  and 
macrophages and the contribution of these pathways for productive infection will likely be distinct 
[4,20,32,33]. With most studies on endocytic HIV entry focusing on adherent cells with engineered 
overexpression of the HIV-1 entry receptor complex, the delineation of the relevance of individual 
entry  pathways  in  physiological  target  cells  including  primary  human  T  lymphocytes  will  be  an 
important future goal. The involvement of specific cytoskeletal elements will serve as a valuable tool 
in  these  studies  that  may  allow  discrimination  between  individual  routes  employed.  Finally,  it  is 
becoming increasingly clear that HIV-1 predominately spreads via cell-cell contacts rather than by 
infection of cell-free virus particles. HIV-1 cell-cell transmission clearly depends on the integrity of Viruses 2011, 3                                       
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the microtubule network and is mediated by F-actin rich, dynamic cell protrusions that may also be 
subject to endocytosis in target cells during productive entry [4,40–43].  
2.2. Transport to Nucleus 
Delivery of the viral core into the cytoplasm is followed by uncoating of the viral genome to release 
it into the host cell cytoplasm where it resides in association with viral proteins in a structure referred 
to as the preintegration complex (PIC). This step has remained the most enigmatic in the life cycle of 
HIV-1 and the molecular mechanism and the subcellular site of uncoating, as well as the composition 
of the PIC are debated [44–46]. Irrespective of the detailed uncoating mechanism, movement of the 
PIC  by  brownian  motion  or  diffusion  is  restricted  by  the  densely  packed  cytoplasm  [47]  and 
translocation to the nucleus therefore requires active transport processes, the nature of which is only 
slowly  beginning  to  emerge.  Both  actin  and  microtubule  dependent  transport  events  have  been 
proposed to play a role [27,28,48]. In this scenario, initial transport through the cortical actin at the cell 
periphery  is  thought  to  rely  on  actin-based  motility  possibly  mediated  by  the  Arp2/3  complex, 
subsequently followed by rapid microtubule dependent delivery towards the nucleus. However, this 
model is mostly based on the imaging of individual incoming viral components in association with 
cytoskeletal elements and how relevant these individual particles are to productive infection is difficult 
to assess. The identification of specific host cell and viral components that govern these individual 
transport  steps  will  greatly  contribute  to  our  understanding  of  this  important  step  in  the  HIV-1 
life cycle. 
2.3. Transcription and Nuclear Export 
Even  though  individual  viral  genes  are  already  expressed  to  some  extent  from  incoming 
cytoplasmic genome copies [49], transcription of the full set of viral genes is only initiated following 
nuclear import and integration of the viral genome into the host cell chromosome. HIV-1 transcription 
is an orchestrated process that depends on the viral transactivator Tat together with several host cell 
transcription initiation, elongation and termination complexes [50]. Little is known about the potential 
involvement  of  the  host  cell  cytoskeleton  in  this  process.  However,  cytoplasmic  remodeling  of  
e.g., actin filaments is known to affect the availability of cytoplasmic transcription factors such as 
MAL  for  translocation  into  the  nucleus  and  thus  for  transcription  of  specific  target  genes  [51]. 
Moreover it is becoming increasingly clear that actin is an abundant component of cell nuclei, where it 
is subject to complex dynamic regulation that may directly impact on transcriptional activity [52,53]. 
Such effects could be directly affected by Tat, which has been reported to affect polymerization states 
of  F-actin  [54,55].  The  promoter  of  the  integrated  HIV-1  genome  is  partially  condensed  into 
nucleosomes to prevent efficient transcript elongation and it is well established that Tat recruits histone 
acetyltransferases (HATs) such as p300/CBP that locally loosen chromatin during transcription [56]. 
Moreover, ATP-driven chromatin remodeling complexes of the SWI/SNF family are also recruited to 
the HIV-1 promoter region, where they cooperate with HATs to allow efficient HIV transcription [57]. 
Importantly, -actin and actin-related proteins represent crucial components of those complexes and 
co-immunoprecipitate  with  HIV-1  Tat,  indicating  that  actin  and  actin  binding  molecules  may 
constitute  crucial  components  of  the  HIV  transcriptional  machinery  [57,58].  Defined  signaling Viruses 2011, 3                                       
 
299 
mechanisms, the role of cytoplasmic as well as nuclear actin turnover and the precise set of actin 
binding proteins involved in this process, however, remain to be unraveled. Since the nuclear export 
factor for unspliced viral RNA, Rev, depends on and colocalizes with nuclear actin-bundles to allow 
efficient viral export, nuclear actin may also play pivotal roles during Rev-dependent nuclear export of 
genomic viral RNA [59]. The advent of novel experimental tools that allow the specific visualization 
and manipulation of nuclear actin [52,53] opens avenues for fascinating studies on the involvement of 
such mechanisms in the HIV-1 life cycle. 
2.4. Budding/Assembly/Release 
Similar to the events during entry of HIV-1 particles in new target cells it could be assumed that 
cytoskeletal  structures  mediate  transport  of  individual  virion  components  to  budding  sites  at  the 
plasma  membrane of producer cells and that the cortical  actin  meshwork constitutes a substantial 
barrier to the release of newly formed virions. However, all available evidence indicates that the late 
steps in the HIV replication cycle depend remarkably little on the host cell cytoskeleton. In particular, 
treatment of HIV-1 producing cells with actin and microtubule disrupting drugs cause little inhibition 
of HIV-1 production [60,61]. Moreover, based on live cell imaging of virus producing HeLa cells, 
addition of the actin disrupting drug LatrunculinA does not exert apparent effects on the position of 
HIV-1 budding structures or the assembly kinetics at individual budding sites [62]. These findings 
raise the question how Gag and the viral genomic RNA are trafficked through the cytoplasm to the 
plasma membrane prior to budding. While this is currently unclear for the HIV-1 genomic RNA, Gag 
could reach the plasma  membrane  by  free diffusion  in  its  monomeric  form  followed by PI(4,5)P2 
dependent recruitment to the plasma membrane where assembly occurs [63,64]. However, associations 
of Gag with actin [65–67] as well as with the microtubule motor KIF4 [64,68] and of the RNA genome 
with proteins that provide a link to the cytoskeleton [69] have been reported, the functional relevance 
of which remain to be delineated. While the cytoskeleton may thus be directly or indirectly involved in 
the transport of virion components, the actual  budding process does not appear to strictly rely  on 
cytoskeleton  remodeling.  In  this  scenario,  the  observed  colocalization  of  F-actin  with  budding 
structures [70] and the packaging of actin and actin binding proteins into HIV-1 virions [71,72] would 
be secondary consequences of the high abundance of these molecules at budding sites. This raises the 
question of how budding HIV-1 virions circumvent the physical block imposed by the actin cortex. In 
principle,  monomeric  Gag  proteins  could  simply  diffuse  through  the  cortical  actin  and  assemble 
underneath  the  plasma  membrane,  thereby  possibly  bypassing  the  diffusion  restriction  imposed  to 
larger,  pre-assembled  complexes.  In  addition,  hijacking  of  the  cellular  ESCRT  machinery  that  is 
essential for late assembly steps and subsequent release of HIV [73] may provide HIV-1 with a built-in 
mechanism that locally destabilizes F-actin for efficient release. Indeed, remodeling of the actin cortex 
is observed at HIV-1 budding sites [70] but may, based on the lack of potent effect of actin remodeling 
inhibitors,  not  be  essential  for  particle  release.  The  role  of  the  cytoskeleton  in  ESCRT  function,  
e.g., during the final steps of cytokinesis [74], has so far not been exhaustively analyzed, but initial 
findings in Drosophila indicate that components of the ESCRT machinery are able to interact with the 
actin cytoskeleton [75].  Viruses 2011, 3                                       
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3. HIV-1 Accessory Proteins and Their Influence on the Cytoskeleton:  
The  accessory  genes  of  HIV-1  have  regulatory  functions  and  facilitate  viral  replication  by 
optimizing the environment for the virus in the infected host. For the HIV-1 accessory proteins Vpu 
and Vpr, no relevant functional interactions with the host cell cytoskeleton have been reported thus far. 
The viral infectivity factor Vif can associate with intermediate filaments [76], whether this is relevant 
for its role as antagonist of the host cell restriction factors of the APOBEC protein family however 
remains  to  be  addressed  [77].  In  contrast  and  as  discussed  in  the  following  in  detail,  the  HIV-1 
accessory  protein  Nef  emerges  as  important  regulator  of  the  cellular  actin  cytoskeleton  in 
infected cells. 
3.1. Nef 
3.1.1 Functions of Nef in HIV-1 Infection 
The lentiviral Nef protein is an important pathogenicity factor that elevates virus replication in vivo 
[78].  Numerous  independent  functions  have  been  attributed  to  this  protein  in  vitro,  including 
alterations of intracellular trafficking, modification of cellular signaling and enhancement of virion 
infectivity  [79–81].  How  these  individual  activities  synergize  to  promote  virus  spread  and 
pathogenesis  in  vivo  remains  to  be  fully  resolved.  Effects  of  Nef  on  F-actin  structures  were  first 
observed in murine fibroblasts where Nef, when expressed with the co-factor Vav, induced potent 
actin depolymerization [82]. Subsequently similar effects of Nef on F-actin structures were reported 
for HIV-1 target cells overexpressing Nef or following HIV-1 infection, and even upon extracellular 
addition of recombinant Nef protein. Genetic approaches revealed that the effects of Nef on actin 
remodeling are not essential for many other Nef activities, thus establishing the interplay of Nef with 
F-actin as an independent function of the pathogenicity factor [83–86].  
3.1.2. Mechanism of Actin Remodeling Inhibition by Nef 
Mapping and functional experiments established that modulation of F-actin organization by Nef 
requires  its  association  with  cellular  membranes  as  well  as  with  the  cellular  kinase  PAK2 
[82,83,85,87]. Over the past years, significant progress was made towards understanding how Nef 
exploits PAK2 to modulate host cell actin dynamics. The Nef-PAK2 association occurs in the context 
of  a  fragile  multiprotein  complex  that  contains  a  highly  active  subpopulation  of  PAK2,  the  
Rho-GTPase Rac1, its guanine nucleotide exchange factor Vav1, as well as several unknown proteins 
[82,88]. Assembling Nef-PAK2 complexes in lipid raft membrane microdomains [89,90], Nef employs 
its  SH3  domain  binding  motif  as  well  as  a  patch  surrounding  a  critical  phenylalanine  near  its  
C-terminus for the recruitment of host cell components [86,91–93]. Even though the identity of the 
direct  interaction  partners  of  these  motifs  remains  to  be  established,  mutation  of  the  critical 
phenyalanine resulted in a mutant Nef protein that is selectively deficient for association with PAK2 
and thus for interference with host cell actin dynamics, but maintains wild type activity for all other 
Nef functions [86,91]. Use of this mutant along with silencing of PAK2 demonstrated that association 
with  PAK2  is  crucial  for  Nef’s  inhibitory  effects  on  the  actin  cytoskeleton  [83,85,87].  A  recent Viruses 2011, 3                                       
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mechanistic study showed that Nef alters the substrate specificity of PAK2 towards the actin severing 
factor  cofilin.  Not  a  PAK2  substrate  in  the  absence  of  Nef,  phosphorylation  of  cofilin  causes  its 
inactivation in HIV-1 infected cells, resulting in reduced actin turnover [83,87]. This Nef function is 
highly conserved among different nef alleles of HIV-1, HIV-2 and SIV [87, 94] and can be observed in 
a wide variety of cell types of different species origin [82,83,95,96]. Interestingly, Nef does not affect 
basal  F-actin  levels  or  morphology  of  quiescent  cells  via  this  mechanism  but  primes  cells  to  be  
non-responsive to most external triggers that induce actin remodeling. Moreover, inhibitory effects of 
Nef  appear  restricted  to  sheet-like  actin  protrusions  as  observed  in  chemokine-induced  plasma 
membrane  ruffles  [83,87,97],  circumferential  F-actin  rich  rings  [84,85]  and  at  the  immunological 
synapse  (IS)  [94]  (Figure  2).  In  contrast,  Nef  does  not  exert  such  inhibition  on  thin  F-actin  rich 
protrusions such as filopodia or nanotubes observed during cell-to-cell transmission of HIV [97,98] 
(Figure 2). 
Figure 2. Nef prevents F-actin turnover in T lymphocytes. Nef is incorporated into lipid 
microdomains via its myristoyl anchor and associates with a labile multiprotein complex of 
about 1 MDa, which contains the cellular kinase PAK2, VAV1, a small Rho GTPase and 
several unknown factors. Interaction surfaces required for complex assembly are known, 
the precise interaction partners, however, are unclear and association may be mediated by 
yet-to-be identified factors (X, Y). Nef associates with a highly active subpopulation of 
PAK2 and redirects it towards the phosphorylation of cofilin to block actin dynamics. This 
inhibition appears to be specific for individual F-actin rich protrusions such as membrane 
ruffles/lamellipodia while the formation of filopodia is not affected by Nef. 
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3.1.3. Functional Consequences of Altered Actin Dynamics in T Lymphocytes 
In  T  lymphocytes,  actin  remodeling  upon  T  cell  receptor  (TCR)  engagement  or  chemokine 
stimulation was identified to be subject to Nef-mediated inhibition [83–85,87,94]. The ability of T 
cells to intimately interact with antigen presenting cells (APCs), by forming a TCR signaling induced 
IS, is central to the initiation of an immune response  [99]. One hallmark of this interaction is the 
pronounced F-actin accumulation at cell-cell contacts. In the case of ISs formed between B cells and 
cognate T cells, this contact is critical for TCR signaling and thus T cell activation. Nef proteins from 
HIV-1, HIV-2 and SIV potently interfere with F-actin remodeling at the IS between infected T cells 
and  superantigen-loaded  B  cells  [94].  In  addition,  Nef  also  affects  intracellular  transport  events 
required for efficient TCR signaling, thus resulting in a marked reduction in TCR proximal signaling 
events [84,100,101]. Despite these blocks to the early steps in the TCR cascade, distal TCR signaling 
is remarkably efficient in HIV-1 infected T cells, while Nef proteins from HIV-2 and SIV efficiently 
shut  down  signaling  by  reducing  cell  surface  exposure  of  CD3-TCR  complexes  [102].  Via  this 
mechanism, HIV-1 Nef may ensure elevated levels of T cell activation required for efficient virus 
replication while preventing T cell hyperactivation and concomitant activation-induced cell death that 
would  limit  virus spread  [103]. Addressing  how HIV-1 Nef  maintains distal TCR signaling while 
disrupting initial events at the IS and which precise role inhibition of actin remodeling plays in this 
context represent important questions for future studies.  
Besides interfering with TCR-induced actin remodeling, Nef also affects chemokine induced actin 
remodeling and accompanied chemotaxis [83,87]. Reflecting the strict requirement of cell motility for 
a precise spatiotemporal control of actin dynamics [3,104], Nef potently interferes with cell motility in 
response to various stimuli in different cell types [83,87,97,105]. Dynamic actin turnover and efficient 
motility are also central to T lymphocyte immune functions  in vivo such as screening for antigen, 
homing  to  lymph  nodes  as  well  as  activation  and  interaction  with  other  immune  cells  [106].  We 
therefore propose that Nef, via inhibition of T lymphocyte chemotaxis, prevents HIV-1 infected T 
lymphocytes  from  homing  into  lymph  nodes  and  scanning  for  cognate  antigen.  Such  failure  in 
migration  towards  the  T  cell  area  in  the  lymph  node  will  prevent  these  T  lymphocytes  from 
encountering B cells, which is crucial B cell activation and subsequent formation of germinal centers, 
where  immunoglobulin  class  switching  and  production  of  high  affinity  antibodies  occurs  [107]. 
Consistent with this model, SIV wildtype infected cells are retained in the paracortex of lymph nodes 
of  SIVmac239-infected  macaques  and  germinal  center  formation  is  prevented,  whereas  SIVNef 
infected cells readily migrate into the area of the germinal center [108]. Nef-mediated inhibition of 
actin remodeling and cell migration may thus interfere with the production of high affinity antibodies, 
thereby contributing to the B cell dysfunction frequently observed in AIDS patients [109]. Since not 
only movement within but also egress from lymph nodes back into the blood circulation represents an 
active  process  that  depends  on  the  migratory  capacity  of  cells,  Nef-mediated  inhibition  of  T 
lymphocyte motility may also retain infected cells inside lymph nodes, thereby keeping them in near 
proximity to susceptible target cells [110]. HIV-1 spread in densely packed lymphoid organs is thought 
to  occur  predominantly  via  the  cell-to-cell  route  [111,112],  a  process  that  relies  on  F-actin  rich 
cytoneme bridges and is per se not affected by Nef [40,98,113,114]. Reduced motility of infected cells 
may however indirectly favor virus transmission to new target cells and account for enhanced virus Viruses 2011, 3                                       
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replication in the presence of Nef in vivo. Together, inhibition of triggered actin remodeling by Nef 
emerges as versatile and important strategy of HIV-1 to adjust T lymphocyte homeostasis in order to 
facilitate viral spread and to impair the immune system of the host, thereby creating an optimal niche 
for viral replication. 
3.1.4. Nef-Mediated Alteration of F-Actin Organization in Other Cell Types 
Besides T lymphocytes Nef also alters actin organization in other HIV-1 target cells by yet-to-be 
established  molecular  mechanisms.  In  macrophages,  filopodia  like  structures  serve  as  long-range 
conduits to transport Nef over long distances inside the lymph node to transfer it to B cells that do not 
represent HIV-1 target cells [115]. Whether Nef itself induces filopodia on macrophages or whether 
existing structures are hijacked is currently unclear. B cells have been shown to contain Nef in lymph 
nodes  of  HIV-infected  patients  and  Nef  interferes  with  immunoglobulin  class  switching,  thereby 
interfering with the production of high affinity antibodies [115,116]. This effect may synergize with 
the Nef-mediated inhibition of T lymphocyte chemotaxis and effects on B cell activation via soluble 
factors [117], suggesting that manipulation of B cell function may constitute a cardinal function of Nef 
in  AIDS  pathogenesis.  Finally,  effects  of  Nef  on  actin  organization  have  also  been  described  for 
podocytes and dendritic cells (DC). Podocytes are specialized cells in the kidney epithelium that can 
be infected by HIV-1 and exhibit an altered actin cytoskeleton upon expression of Nef [118]. The 
observed phenotype however clearly differs from that observed in T lymphocytes as lamellipodia and 
F-actin stress fibers are induced and may involve a distinct molecular mechanism that relies on the 
interaction of Nef with the diaphanous interacting protein. Finally, induction of F-actin rich plasma 
membrane ruffles and uropods have been observed following incubation of DCs with extracellular Nef 
[119], however mechanism and functional relevance of this phenomenon have not yet been explored.  
4. Conclusion  
HIV-1 takes advantage of the cellular cytoskeleton at various steps in its replication cycle, most 
intriguingly is the involvement of the actin machinery during the entry process. However, knowledge 
is limited at other steps of the replication cycle and future work will be required to shed light on these 
black boxes of HIV replication. The accessory protein Nef emerges as a major regulator of the actin 
cytoskeleton in an HIV infected cell and we are only beginning to understand how the virus benefits 
from hijacking host cell actin dynamics. Improved imaging techniques and labeling strategies as well 
as the development of new experimental tools will allow us to further dissect the role of the cellular 
cytoskeleton for HIV-1 replication and pathogenesis. 
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